How do you factor time from past cytotoxic chemotherapy exposure into diagnosing therapy-related AML?

Topics: Medical Oncology • Leukemia • AML

Many patients have had prior chemotherapy exposure with newly diagnosed AML that may not have classic therapy-related cytogenetics. How do you approach this scenario?

Answer from: Medical Oncologist at Community Practice

The WHO criteria do not specify a defined time criteria for the diagnosis of therapy-related AML. WHO writes, "Most cases of t-AML present within 10 years of the most recent exposure, and the origin of AML in cases with very long latent periods may be unrelated to therapy." But even if a patient pre...

Comments

Medical Oncologist at Conway Regional Health System
Thank you!

Related Questions